This review summarizes the diagnostic, therapeutic, and prognostic utility of natriuretic peptides in left ventricular failure.
Answers are grounded in this paper and cite their sources.
May inform natriuretic peptide use in left ventricular failure; leaves open need for updated randomized validation.
Left ventricular failure (LVF) is a clinical syndrome caused by abnormal systolic or diastolic function failing to meet the metabolic requirements of the body. It is important to diagnose and manage LVF in the earliest stages to prevent mortality and morbidity. This article extensively reviews the diagnostic, therapeutic, and prognostic utility of natriuretic peptides in LVF.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: